Jeff Ubersax: Demetrix, Yeast & Rare Cannabinoids | Good Chemistry #14 | Supported by Demetrix

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email



Nick talks to Jeff Ubserax, PhD, CEO of the biotechnology company Demetrix (who supported this episode). Jeff discussed the science behind how Demetrix is engineering baker’s yeast to produce cannabinoids at an industrial scale, with a focus on making rare cannabinoids other than THC and CBD.

Jeff also discussed how he transitioned from academic science to running his own company, and offered advice for academic scientists in training who might be thinking about moving into biotechnology.

Download Good Chemistry podcast audio & support Nick:
https://nickjikomes.com​​​

Connect with Nick Jikomes on Twitter:
https://twitter.com/trikomes​​​​

About Nick Jikomes:

Nick is a neuroscientist and podcast host. He is currently Director of Science & Innovation at Leafly, the world’s largest cannabis information resource. He received a Ph.D. in Neuroscience from Harvard University and a B.S. in Genetics from the University of Wisconsin-Madison.

0:00:00​ Intro
0:06:10 Engineering Yeast Metabolism
0:15:20 Cannabinoid Production in Yeast
0:24:31 Scale of Cannabinoid Production
0:32:52 How Long Does This Process Take?
0:38:02 Economics of This Production Method
0:49:44 Jeff’s Transition From Academic to Industry
0:56:26 Advice for Grad Students & Postdocs
0:59:42 Origins of Demetrix
1:05:52 Next Steps For Industrial Cannabinoid Production
1:09:35 How Many Employees Are Scientists?
1:13:59 Final Thoughts

View original source video by clicking here

On Key

Related Posts

Cannabis Vacations

New laws legalizing the recreational use of Marijuana have sparked interest all over the world to destinations in the United States, especially Colorado. Our friends